Scott B. Brown is CFO at Tracon Pharmaceuticals, Inc. (TCON). They have made 5 open-market trades across 1 company since 2021, most recently 2023-04-20.
CIK 0001789822
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $25K since 2021, never a sale. Across 5 scored buys the stock is down 11.5% at ninety days, and 12.8 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| TCON | 25,128 | $36K |
Shares reported on the most recent Form 4, priced at the 2024-03-13 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 40% | 20% |
| Avg Move | +4.4% | -1.7% | -11.5% |
| Alpha | +5.5% | -0.8% | -12.8% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TCON | BUY | 2022-12-29 | 2023-01-03 | $1.49 | $5K | +18.9% | +15.3% | +29.7% |
| TCON | BUY | 2022-09-12 | 2022-09-14 | $2.02 | $5K | -10.9% | -13.5% | -31.4% |
| TCON | BUY | 2022-03-29 | 2022-03-30 | $2.82 | $3K | -7.7% | -24.4% | -25.6% |
| TCON | BUY | 2021-08-13 | 2021-08-17 | $3.69 | $4K | +14.4% | +14.4% | -2.4% |
| TCON | BUY | 2021-03-08 | 2021-03-09 | $8.30 | $8K | +7.2% | -0.2% | -28.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.